1. Home
  2. CSWC vs AXGN Comparison

CSWC vs AXGN Comparison

Compare CSWC & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Capital Southwest Corporation

CSWC

Capital Southwest Corporation

HOLD

Current Price

$22.21

Market Cap

1.4B

ML Signal

HOLD

Logo Axogen Inc.

AXGN

Axogen Inc.

HOLD

Current Price

$28.52

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSWC
AXGN
Founded
1961
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Textiles
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.5B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
CSWC
AXGN
Price
$22.21
$28.52
Analyst Decision
Buy
Strong Buy
Analyst Count
5
9
Target Price
$23.50
$36.11
AVG Volume (30 Days)
588.7K
762.2K
Earning Date
01-01-0001
05-15-2026
Dividend Yield
11.40%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$225,208,000.00
Revenue This Year
$16.83
$19.81
Revenue Next Year
$10.26
$16.31
P/E Ratio
$12.65
N/A
Revenue Growth
N/A
20.21
52 Week Low
$17.47
$9.22
52 Week High
$23.84
$36.00

Technical Indicators

Market Signals
Indicator
CSWC
AXGN
Relative Strength Index (RSI) 42.11 31.36
Support Level $20.42 $23.00
Resistance Level $23.06 $34.26
Average True Range (ATR) 0.54 1.49
MACD -0.06 -0.64
Stochastic Oscillator 46.00 4.29

Price Performance

Historical Comparison
CSWC
AXGN

About CSWC Capital Southwest Corporation

Capital Southwest Corp is a U.S.-based investment company that specializes in providing customized financing to middle market companies across various industries. The company's investment objective is to produce attractive risk-adjusted returns by generating current income from debt investments and capital appreciation from equity and equity related investments. It focuses on providing flexible financing solutions through partnerships with business owners, management teams, and financial sponsors. The company's portfolio may include senior debt, second lien, and subordinated debt, preferred stocks, common stocks, and warrants. The primary source company's revenue comprises interest income and dividend income from investments made as well as management fees.

About AXGN Axogen Inc.

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.

Share on Social Networks: